U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C31H27F2N5O3S2
Molecular Weight 619.705
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLESATINIB

SMILES

COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(OC4=CC=C(NC(=S)NC(=O)CC5=CC=C(F)C=C5)C=C4F)=C3S2

InChI

InChIKey=YRCHYHRCBXNYNU-UHFFFAOYSA-N
InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)

HIDE SMILES / InChI
Molecular Formula C31H27F2N5O3S2
Molecular Weight 619.705
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
123738
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:36:26 UTC 2023
Edited
by admin
on Sat Dec 16 10:36:26 UTC 2023
Record UNII
7Q29OXD98N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLESATINIB
WHO-DD  
USAN   INN  
Official Name English
MG90265
Code English
Glesatinib [WHO-DD]
Common Name English
MGCD-265
Code English
MGCD265
Code English
MG-90265X
Code English
GLESATINIB [USAN]
Common Name English
MG-90265
Code English
MG90265X
Code English
BENZENEACETAMIDE, 4-FLUORO-N-(((3-FLUORO-4-((2-(5-(((2-METHOXYETHYL)AMINO)METHYL)-2-PYRIDINYL)THIENO(3,2-B)PYRIDIN-7-YL)OXY)PHENYL)AMINO)THIOXOMETHYL)-
Systematic Name English
glesatinib [INN]
Common Name English
N-(3-FLUORO-4-(2-(5-((2-METHOXYETHYLAMINO) METHYL)PYRIDINE-2-YL)THIENO(3,2-B)PYRIDINE-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-(4-FLUOROPHENYL)ACETAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C129825
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
NCI_THESAURUS C1967
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
Code System Code Type Description
CAS
1044577-56-1
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
NO STRUCTURE GIVEN
INN
10217
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
DRUG BANK
DB06302
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
NCI_THESAURUS
C77876
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
FDA UNII
7Q29OXD98N
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
WIKIPEDIA
Glesatinib
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
USAN
DE-141
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
CAS
1072115-99-1
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
NO STRUCTURE GIVEN
PUBCHEM
25181472
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
CAS
936694-12-1
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
ChEMBL
CHEMBL254760
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
EPA CompTox
DTXSID601337113
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
SMS_ID
100000175671
Created by admin on Sat Dec 16 10:36:26 UTC 2023 , Edited by admin on Sat Dec 16 10:36:26 UTC 2023
PRIMARY
Related Record Type Details
ANGIOPOIETIN-1 RECEPTOR
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
IC50
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
IC50
MACROPHAGE-STIMULATING PROTEIN RECEPTOR
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
IC50
HEPATOCYTE GROWTH FACTOR RECEPTOR
TARGET -> INHIBITOR
Structure of GLESATINIB GLYCOLATE
SALT/SOLVATE -> PARENT
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
IC50
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3
TARGET -> INHIBITOR
COMPETITIVE INHIBITOR
IC50
Related Record Type Details
Structure of GLESATINIB
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966